Skip to content
healthcare.dev

pyridostigmine bromide

NDC 65841-819, pyridostigmine bromide, tablet, from Zydus Lifesciences Limited.

Product NDC
65841-819
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205650
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65841-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE60 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
65841-819-0165841081901100 TABLET in 1 BOTTLE (65841-819-01)
65841-819-0565841081905500 TABLET in 1 BOTTLE (65841-819-05)
65841-819-066584108190630 TABLET in 1 BOTTLE (65841-819-06)
65841-819-166584108191690 TABLET in 1 BOTTLE (65841-819-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea4f753f-41a0-4f82-932c-181883d4b6d3

Use it

Look up 65841-819 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65841-819 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65841-819. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.